Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 104 Neoplasms 13 Neoplasm Metastasis 8 Sarcoma 6 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Liposarcoma 4 Multiple Myeloma 3 Head and Neck Neoplasms 3 Glioblastoma 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Breast Diseases 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasm, Residual 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Inflammation 2 Estrogen Receptor-positive Breast Cancer 2 Esophageal Squamous Cell Carcinoma 2

Interventions

Temozolomide 85 Radiotherapy 51 Bevacizumab 31 Irinotecan 19 Radiation 16 Carmustine 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 O(6)-benzylguanine 11 Chemotherapy, Adjuvant 11 Carboplatin 9 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Filgrastim 8 Surgical Procedures, Operative 6 Gene Expression Profiling 6 Drug Therapy 6 pembrolizumab 5 aldesleukin 5 Topotecan 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 Etoposide 5 Sorafenib 4 Immunohistochemistry 4 Dasatinib 4 Celecoxib 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡